摘要
目的:观察丁苯酞胶囊治疗急性期脑梗死患者引起肢体障碍的临床疗效。方法:将126例脑梗死患者在常规神经内科处理的基础上随机分成两组,对照组用0.9%氯化钠溶液250ml加血塞通冻干粉400mg静点。治疗组用0.9%氯化钠溶液加复方丹参注射液16ml每日静点1次,另加口服丁苯酞软胶囊1次2粒,1d4次。两组均14d为1个疗程。结果:疗程结束后,患者上、下肢肌力均有明显改善。经过1个疗程的治疗对照组Barthel指数由42.25上升到68.50,而治疗组Barthel指数由41.20上升到83.50。治疗前后比较,P<0.01,差异具有统计学意义。结论:丁苯酞软胶囊对于脑缺血发作的患者具有明显的改善肢体功能作用,有较好的临床疗效。
Objective: To observate the clinical curative effect of butylenyl phthaline capsule in the treatment of patients with limb moving obstacle caused by acute cerebral infarction. Methods: One hundred and twenty six cases of cerebral infarction patients in treatment on the basis of general neurology were divided into two groups, control group were treated with 0.9% normal saline 250 ml and Xuesaitong powder 400 mg. Treatment group were treated with 0.9% saline solution and compound danshen injections 16 ml, 1 time a day, oral butylenyl phthaline soft capsule in treatment group two capsules each time, four times a day, 14 days for a course. Results: After the end of the course, upper and lower limb muscle strength in patients was improved markedly. Barthel index of control group rose to 68.50 from 42.25, Barthel index of treatment group rose to 83.50 from 41.20, the difference was statistically significant (P〈0.01). Conclusion: Butylenyl phthaline soft capsule for patients with cerebral ischemic attack has a significant role in improving limb function, there is better clinical curative effect.
出处
《中国当代医药》
2011年第35期70-71,共2页
China Modern Medicine
关键词
脑梗死
丁苯酞
临床观察
肢体活动障碍
Cerebral infarction
Butylenyl phthaline
Clinical observation
Limb moving obstacle